Inventor
LALEZARI IRAJ
US19 patents
⚠️ This page may combine multiple inventors who share the name “LALEZARI IRAJ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MONTEFIORE MED CENTER
10 patentsUS5292935AMar 8, 1994
Method of synthesis and novel compounds for pharmaceutical uses
MONTEFIORE MED CENTER14 citations81
US5268500ADec 7, 1993
Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
MONTEFIORE MED CENTER20 citations81
US5093367AMar 3, 1992
Method of synthesis and novel compounds for pharmaceutical uses
MONTEFIORE MED CENTER16 citations81
US4418059ANov 29, 1983
Nucleoside ester compositions
MONTEFIORE MED CENTER8 citations73
US5962651AOct 5, 1999
Modified hemoglobin and its use as a component of an artificial blood substitute
MONTEFIORE MED CENTER13 citations72
US4921997AMay 1, 1990
Method of synthesis and novel compounds for pharmaceutical uses
MONTEFIORE MED CENTER15 citations72
US5498708AMar 12, 1996
Method of synthesizing polyesters
MONTEFIORE MED CENTER5 citations62
US4780542AOct 25, 1988
Process for the synthesis of esters and amides of carboxylic acids
MONTEFIORE MED CENTER5 citations62
US6072072AJun 6, 2000
Compounds for preparing modified hemoglobin
MONTEFIORE MED CENTER1 citations51
US5472981ADec 5, 1995
Method of synthesis and novel compounds for pharmaceutical uses
MONTEFIORE MED CENTER0 citations51
HOPE CITY
3 patentsUS6605642B2Aug 12, 2003
Inhibitors of formation of advanced glycation endproducts (AGES)
HOPE CITY23 citations92
US6337350B1Jan 8, 2002
Inhibitors of formation of advanced glycation endproducts (AGEs)
HOPE CITY47 citations92
US7030133B2Apr 18, 2006
Inhibitors of formation of advanced glycation endproducts (AGEs)
HOPE CITY8 citations73